Patients in Europe Now Have Access to Cutting-Edge Immunotherapy in Phase II Clinical Trial

NASHVILLE, TENN., June 1, 2018 – Sarah Cannon announced today the appointment of three new research faculty to its drug development programs ...

Collaboration between Early Phase Research Leader, Sarah Cannon Research Institute and the NCI-Designated Sidney Kimmel Cancer Center – Jefferson...

NASHVILLE, TENN., May 31, 2018 – Sarah Cannon announced today that Axel Grothey, MD, has been appointed the new Director of Gastrointestinal ...

NASHVILLE, TENN., May 31, 2018 – Today, Sarah Cannon announced that it will present its latest cancer research insights through more than 85 ...

NASHVILLE, TENN., May 30, 2018 – Today, Sarah Cannon announced the promotion of William Donnellan, MD, to Director of Leukemia/Myelodysplastic...

• New collaboration aims to further accelerate the delivery of novel treatments for multiple difficult-to-treat cancers • Collaboration will ...

NASHVILLE, Tenn., February 21, 2018 - Today, Sarah Cannon, the Cancer Institute of HCA Healthcare, announced that 18 abstracts authored by members...

Dr. Amita Patnaik and Dr. Kyriakos Papadopoulos Appointed Co-Directors of Clinical Research

Today, Sarah Cannon announced the promotion of Johanna C. Bendell, MD, to Chief Development Officer.